Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-18073.5US
CA.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CA.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.28ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.28NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DG.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DG.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.56ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.56NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDP.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HN.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HN.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
HN.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KL.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KL.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KL.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HK.24.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.24.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.24.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.24.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.2.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.2.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-6672.85US
FL.1.5.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.1.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.1.5.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HE.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used